‘Breakthrough’ Drug Combination Is Changing The Lives Of Cystic Fibrosis Patients, But There’s A Catch

Shutterstock image via user

Daily Caller News Foundation logo
Evie Fordham Politics and Health Care Reporter
Font Size:

Researchers have found a “breakthrough” drug combination for people with cystic fibrosis, but it has a catch, scientists who conducted two separate studies wrote Thursday in the New England Journal of Medicine.

A three-drug cocktail could help cystic fibrosis patients live longer than they would taking just two of the drugs, which is current protocol, reported NBC News. But the current drug combination costs $300,000 a year, and with the third drug, the price will only go up.

Race finishers cross the finish line during Boomer's Cystic Fibrosis "Run To Breathe" Charity Event at Central Park Bandshell on April 1, 2017 in New York City. Donna Ward/Getty Images

Race finishers cross the finish line during Boomer’s Cystic Fibrosis “Run To Breathe” Charity Event at Central Park Bandshell on April 1, 2017 in New York City. Donna Ward/Getty Images

“These results represent a major breakthrough in cystic fibrosis therapeutics, with the potential for improving health and possibly survival in all patients who carry the most common CFTR mutation,” Dr. Fernando Holguin of the University of Colorado wrote in an editorial that accompanied the research.

“Within 24 hours of taking the pill combination, patients were puffing less. Their sinuses were clearer. They had more energy,” pulmonologist Dr. Jennifer Taylor-Cousar, who led one of the study teams, told NBC News. (RELATED: CDC Searches For Answers On Why Mysterious Polio-Like Disease Is Flaring Up In US Children)

Many cystic fibrosis patients rely on help affording medicine from groups like the Cystic Fibrosis Foundation or personal crowdfunding efforts.

Cystic fibrosis is a rare disease that affects roughly 30,000 people in the U.S., according to the Cystic Fibrosis Foundation. Cystic fibrosis is caused by a defective genes that causes a buildup of mucus in the lungs and pancreas. Individuals with cystic fibrosis have a much lower life expectancy than their peers.

Follow Evie on Twitter @eviefordham.

Send tips to

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact